Table 1.
Antimicrobial Agent |
% Resistance a | |||
---|---|---|---|---|
Total of KPC-Kp Isolates (n = 116) |
2018 (n = 62) |
2019 (n =31) |
2020 (n = 23) |
|
Ceftazidime-avibactam | 8.6% 10/116 |
6.5% (4/62) |
12.9% (4/31) |
8.7% (2/23) |
Meropenem-vaborbactam | 9.5% 11/116 |
14.5% (9/62) |
3.2% (1/31) |
4.3% (1/23) |
Imipenem-relebactam | 2.6% 3/116 |
1.6% (1/62) |
3.2% (1/31) |
4.3% (1/23) |
a Applying EUCAST breakpoints.